Conferences
SUO 2024: The Efficacy of Salvage BCG for Recurrent Non-muscle Invasive Bladder Cancer After First-line Gemcitabine and Docetaxel
December 5, 2024
SUO 2024: Top Papers in Testicular Cancer 2024
December 5, 2024
SUO 2024: Trial Design for BCG Unresponsive NMIBC: Time to Move Past Single Arm Registration Trials?
December 5, 2024
SUO 2024: Spotting Metastatic Masqueraders: How to Avoid Inappropriate Chemotherapy Administration for Testicular Cancer
December 5, 2024
SUO 2024: Advances in RCC Molecular Imaging and Theranostics
December 5, 2024
SUO 2024: Evaluation of Response to 177Lu-PSMA-617 by Site Specific Disease in Metastatic Castrate-Resistant Prostate Cancer
December 5, 2024
SUO 2024: Updates to Testicular Cancer Epidemiology
December 5, 2024
SUO 2024: Artificial Intelligence in RCC Diagnosis and Treatment
December 5, 2024
SUO 2024: Strategies for RPLND in Metastatic Testicular Seminoma
December 5, 2024
CG Oncology Announces Bond-003 Topline Results
December 5, 2024
SUO 2024: Adjuvant Systemic Therapy in Urothelial Carcinoma: Where Are We At Today?
December 5, 2024